Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amplitude Inc (AMPL) vs Novartis AG (NVS) Price & Performance

Amplitude IncTrade
Novartis AGTrade

Price performance (Past 24H)

Key statistics

Amplitude Inc vs Novartis AG — how do they compare? Amplitude Inc trades at $12.78 (market cap $1.59B), while Novartis AG trades at $152.4 (market cap $295.37B). The key difference: Novartis AG is far larger — about 185.8× Amplitude Inc's market cap, and Novartis AG pays a 3.07% dividend while Amplitude Inc pays none. Which is the better fit depends on your goals.

AMPLNVS
Market Cap
$1.59B$295.37B
Sector
TechnologyHealth
52-Week High
$12.69$168.62
52-Week Low
$5.61$119.31
Enterprise Value
$1.45B$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amplitude Inc

Amplitude Inc is pioneering a new category of software called digital optimization. The company's digital optimization system serves as the command center for businesses to connect digital products to business outcomes.

Read more on AMPL

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS